Clinical Trial Update: Safety of Imovax Polio in Chinese Infants and Children [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of Imovax Polio in Chinese infants and children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• IMOVAX Polio (inactivated poliovirus vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED